Which advantages over its rivals hold up, and why are they hard to copy?
The advantage that rivals find hardest to copy is Exosens' manufacturing footprint: with production and research and development running on 12 sites in Europe and North America and over 2,000 employees, and a firm order from Theon for 25,000 4G+ image intensifier tubes, a rival must construct comparable plant capacity before it can serve those same night vision programs.
The order carries options that could raise the total to 60,000 image intensifier tubes.
What could change its growth trajectory, and what would confirm it?
Exosens' growth now turns on whether added capacity arrives faster than demand: revenue rose 18.0% to 386.9 million euros in the first nine months of 2026 while demand continued to exceed available production capacity. Image intensifier tube capacity is planned to rise 40% across Europe and the U.S. by 2027, with the European first phase implemented, and that planned increase is the indicator that confirms or weakens the trajectory.
Photonis Defense was awarded a first delivery order for 1,600 complete systems in August 2026. Exosens confirmed an upgraded 2026 outlook of about 20% revenue growth. It plans to triple thermal camera capacity and double cooled infrared camera capacity in 2026.
What does the product do for its buyer, and how is it delivered?
Exosens supplies cameras, detection hardware and image intensifier tubes as either finished components or complete solutions, so buyers in defense, life sciences, industrial control and nuclear can source a detection function from one supplier. Its range also covers infrared and hyperspectral systems, particle and radiation detectors, and wavefront sensors, offered as components and systems for detection and imaging.
Photonis, Xenics, Emberion and El-Mul now sell their products under the Exosens brand.

Exosens produces imaging, infrared, hyperspectral and radiation detection instruments for life sciences, industrial, nuclear and defense markets.